These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 26525215)
1. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy. Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review. Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188 [TBL] [Abstract][Full Text] [Related]
3. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool. Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414 [TBL] [Abstract][Full Text] [Related]
4. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma. King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976 [TBL] [Abstract][Full Text] [Related]
5. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534 [TBL] [Abstract][Full Text] [Related]
6. Early outcomes of uveal melanoma treated with intraoperative ultrasound guided brachytherapy using custom built plaques. Tann AW; Teh BS; Scarboro SB; Lewis GD; Bretana ME; Croft PC; Raizen Y; Butler EB; Kim RS; Chevez-Barrios P; Schefler AC Pract Radiat Oncol; 2017; 7(4):e275-e282. PubMed ID: 28377140 [TBL] [Abstract][Full Text] [Related]
7. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA. McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456 [TBL] [Abstract][Full Text] [Related]
9. Pigmented episcleral deposits after brachytherapy of uveal melanoma. Toivonen P; Kivelä T Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837 [TBL] [Abstract][Full Text] [Related]
10. Plaque brachytherapy for uveal melanoma: a vision prognostication model. Khan N; Khan MK; Bena J; Macklis R; Singh AD Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e285-90. PubMed ID: 22658514 [TBL] [Abstract][Full Text] [Related]
11. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques. Puusaari I; Heikkonen J; Kivelä T Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045 [TBL] [Abstract][Full Text] [Related]
12. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series. McCannel TA; McCannel CA Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588 [TBL] [Abstract][Full Text] [Related]
14. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma. van Ginderdeuren R; van Limbergen E; Spileers W Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122 [TBL] [Abstract][Full Text] [Related]
15. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes. Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808 [TBL] [Abstract][Full Text] [Related]
16. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma. Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084 [TBL] [Abstract][Full Text] [Related]
17. Ocular complications after iodine brachytherapy for large uveal melanomas. Puusaari I; Heikkonen J; Kivelä T Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335 [TBL] [Abstract][Full Text] [Related]
18. Temporal Relationship Between Visual Field, Retinal and Microvascular Pathology Following 125I-Plaque Brachytherapy for Uveal Melanoma. Tamplin MR; Deng W; Garvin MK; Binkley EM; Hyer DE; Buatti JM; Ledolter J; Boldt HC; Kardon RH; Grumbach IM Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):3. PubMed ID: 33393969 [TBL] [Abstract][Full Text] [Related]
19. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924 [TBL] [Abstract][Full Text] [Related]
20. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]